Phosphorus and risk of renal failure in subjects with normal renal function

American Journal of Medicine

Volumn 126, Issue 4, 2013, Pages 311-318

  Sim, John J ^a   Bhandari, Simran K ^a   Smith, Ning ^b   Chung, Joanie ^b   Liu, In Lu A ^b   Jacobsen, Steven J ^b   Kalantar Zadeh, Kamyar ^c  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b Kaiser Permanente Southern California ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

End stage renal disease risk; Epidemiology; Outcomes; Phosphorus

Indexed keywords

PHOSPHORUS;

ADULT; ARTICLE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEALTH CARE ACCESS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION;

ADULT; AGED; ANALYSIS OF VARIANCE; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHORUS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84875213134     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.08.018     Document Type: Article

References (39)

1. G.A. Block, T.E. Hulbert-Shearon, N.W. Levin, F.K. Port Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 31 4 1998 607 617
2. G.A. Block, P.S. Klassen, J.M. Lazarus, N. Ofsthun, E.G. Lowrie, G.M. Chertow Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 8 2004 2208 2218
3. K. Kalantar-Zadeh, N. Kuwae, D.L. Regidor Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients Kidney Int 70 4 2006 771 780
4. J. Kendrick, M. Chonchol The role of phosphorus in the development and progression of vascular calcification Am J Kidney Dis 58 5 2011 826 834
5. W.G. Goodman, G. London, K. Amann Vascular calcification in chronic kidney disease Am J Kidney Dis 43 3 2004 572 579
6. P. Raggi, G.M. Chertow, P.U. Torres ADVANCE Study Group The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis Nephrol Dial Transplant 26 4 2011 1327 1339
7. J. Floege, M. Ketteler Vascular calcification in patients with end-stage renal disease Nephrol Dial Transplant 19 Suppl 5 2004 V59 V66
8. R. Westenfeld, W. Jahnen-Dechent, M. Ketteler Vascular calcification and fetuin-A deficiency in chronic kidney disease Trends Cardiovasc Med 17 4 2007 124 128
9. R. Dhingra, L.M. Sullivan, C.S. Fox Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community Arch Intern Med 167 9 2007 879 885
10. R.N. Foley, A.J. Collins, C.A. Herzog, A. Ishani, P.A. Kalra Serum phosphorus levels associate with coronary atherosclerosis in young adults J Am Soc Nephrol 20 2 2009 397 404
11. B. Kestenbaum, J.N. Sampson, K.D. Rudser Serum phosphate levels and mortality risk among people with chronic kidney disease J Am Soc Nephrol 16 2 2005 520 528
12. C.P. Kovesdy, K. Kalantar-Zadeh Serum phosphorus and the risk of progression of chronic kidney disease Nephrol Dial Transplant 22 12 2007 3679 3680
13. S. Schwarz, B.K. Trivedi, K. Kalantar-Zadeh, C.P. Kovesdy Association of disorders in mineral metabolism with progression of chronic kidney disease Clin J Am Soc Nephrol 1 4 2006 825 831
14. N. Voormolen, M. Noordzij, D.C. Grootendorst High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients Nephrol Dial Transplant 22 10 2007 2909 2916
15. C. Zoccali, P. Ruggenenti, A. Perna REIN Study Group Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition J Am Soc Nephrol 22 10 2011 1923 1930
16. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 6 1999 461 470
17. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
18. C.P. Kovesdy, J.E. Anderson, K. Kalantar-Zadeh Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease Clin Nephrol 73 4 2010 268 275
19. L.A. Stevens, J. Coresh, H.I. Feldman Evaluation of the modification of diet in renal disease study equation in a large diverse population J Am Soc Nephrol 18 10 2007 2749 2757
20. A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
21. A. Levin, G.L. Bakris, M. Molitch Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney Int 71 1 2007 31 38
22. S.K. Ganesh, A.G. Stack, N.W. Levin, T. Hulbert-Shearon, F.K. Port Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 10 2001 2131 2138
23. J.P. Chen, M.L. Chua, B. Zhang Effects of competitive ions, humic acid, and pH on removal of ammonium and phosphorous from the synthetic industrial effluent by ion exchange resins Waste Manag 22 7 2002 711 719
24. C.M. Giachelli, M.Y. Speer, X. Li, R.M. Rajachar, H. Yang Regulation of vascular calcification: roles of phosphate and osteopontin Circ Res 96 7 2005 717 722
25. S. Jono, M.D. McKee, C.E. Murry Phosphate regulation of vascular smooth muscle cell calcification Circ Res 87 7 2000 E10 E17
26. J.R. Stubbs, S. Liu, W. Tang Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice J Am Soc Nephrol 18 7 2007 2116 2124
27. M. Kuro-o, Y. Matsumura, H. Aizawa Mutation of the mouse klotho gene leads to a syndrome resembling ageing Nature 390 6655 1997 45 51
28. L. Tang, K. Both, R. Taylor ACE inhibition and fibroblast growth factor in cultured human vascular smooth muscle Vasc Med 4 3 1999 129 134
29. J. Stubbs, S. Liu, L.D. Quarles Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease Semin Dial 20 4 2007 302 308
30. M.I. Yilmaz, A. Sonmez, M. Saglam FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease Kidney Int 78 7 2010 679 685
31. J. Kendrick, A.K. Cheung, J.S. Kaufman FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis J Am Soc Nephrol 22 10 2011 1913 1922
32. O.M. Gutierrez, M. Mannstadt, T. Isakova Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 6 2008 584 592
33. C. Faul, A.P. Amaral, B. Oskouei FGF23 induces left ventricular hypertrophy J Clin Invest 121 11 2011 4393 4408
34. T. Isakova, O.M. Gutierrez, Y. Chang Phosphorus binders and survival on hemodialysis J Am Soc Nephrol 20 2 2009 388 396
35. M. Lotz, R. Ney, F.C. Bartter Osteomalacia and debility resulting from phosphorus depletion Trans Assoc Am Physicians 77 1964 281 295
36. M. Lotz, E. Zisman, F.C. Bartter Evidence for a phosphorus-depletion syndrome in man N Engl J Med 278 8 1968 409 415
37. S.E. Silvis, P.D. Paragas Jr Paresthesias, weakness, seizures, and hypophosphatemia in patients receiving hyperalimentation Gastroenterology 62 4 1972 513 520
38. E. Fiaccadori, E. Coffrini, C. Fracchia, C. Rampulla, T. Montagna, A. Borghetti Hypophosphatemia and phosphorus depletion in respiratory and peripheral muscles of patients with respiratory failure due to COPD Chest 105 5 1994 1392 1398
39. F. Tentori, M.J. Blayney, J.M. Albert Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 52 3 2008 519 530